Regulator Dismisses Curaleaf's Bid to Halt Aurora's ATM Program
ACB sits 52% above its 52-week low of $2.56.
Summary
The Alberta Securities Commission dismissed Curaleaf's application to halt Aurora's at-the-market program and confirmed the program complies with securities laws. That removes a legal overhang on Aurora's main equity-raise tool while the hostile bid is live. Aurora also reaffirmed the ATM hasn't been used since August 18, 2026, so no dilution has occurred during the bid process. The ruling follows Aurora's September 14 response calling the application a distraction from Curaleaf's inadequate US$4.00-per-share revised bid, which the board unanimously recommends shareholders reject. The takeover fight remains the dominant driver; the next hard date is the bid's expiry, which the company has not restated here.
At the time of this announcement, ACB was trading at $3.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $255.1M. The 52-week trading range was $2.56 to $6.36. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.